0 Yorumlar
0 hisse senetleri
1K Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Global Molecular Point of Care Testing (Using NAAT) Market: Diagnostic Innovation, Testing Trends, Demand, and OutlookAccording to the latest report published by Data Bridge Market Research, the Molecular Point of Care Testing (using NAAT) Market CAGR Value The global molecular point of care testing (using NAAT) market size was valued at USD 37.93 billion in 2024 and is expected to reach USD 86.17 billion by 2032, at a CAGR of 1.08% during the forecast period...0 Yorumlar 0 hisse senetleri 769 Views 0 önizleme
-
Immunoprotein Diagnostic Testing Market Size, Share, Trends, Growth Opportunities, Key Drivers and Competitive Outlook" According to the latest report published by Data Bridge Market Research, the Immunoprotein Diagnostic Testing Market The global immunoprotein diagnostic testing market size was valued at USD 9.60 billion in 2024 and is expected to reach USD 16.75 billion by 2032, at a CAGR of 7.20% during the forecast periodThe market growth is largely fueled by the increasing prevalence of chronic...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Immunoprotein Diagnostic Testing Market Size, Share, Trends, Growth Opportunities, Key Drivers and Competitive Outlook" According to the latest report published by Data Bridge Market Research, the Prenatal Genetic Testing Market Data Bridge Market Research analyses that the prenatal genetic testing market, which was USD 9,969.2 million in 2022, would rise to USD 29,042.3 million by 2030 and is expected to undergo a CAGR of 14.3% during the forecast period 2023 to 2030. In addition to the insights on...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Clonality-Based Testing Using ABI Fluorescence Detection: Advancing Precision in Hematologic DiagnosticsIn modern oncology and molecular diagnostics, the ability to accurately identify and characterize clonal cell populations has become essential. Clonality-based testing, particularly using ABI fluorescence detection, plays a critical role in diagnosing and monitoring hematological malignancies such as leukemia and lymphoma. With advancements in PCR-based technologies and capillary...0 Yorumlar 0 hisse senetleri 12K Views 0 önizleme
-
Immunoassay Market Growth Finds Fresh Opportunities in Decentralized TestingThe immunoassay market is entering a period of steady expansion as healthcare systems increasingly prioritize early disease detection, biomarker analysis, personalized medicine, and rapid diagnostic testing. The market was valued at USD 28.0 billion in 2025 and is estimated to reach USD 29.3 billion in 2026, before growing to USD 40.3 billion by 2033. It is projected to expand at a 4.6% CAGR...0 Yorumlar 0 hisse senetleri 80 Views 0 önizleme
-
Immunoassay Market: ELISA, CLIA Tech & Kits/Reagents Diagnostic Analysis" Exactitude Consultancy That Adds Flavour To Your Success" Immunoassay Market size and trends. ELISA and CLIA diagnostics for infectious diseases, oncology, and endocrinology in hospital labs. The global Immunoassay Market is projected to reach USD 34.50 Billion in 2026 and USD 52.40 Billion by 2033, growing at a 6.1% CAGR. If you're looking for insights into the Immunoassay Market,...0 Yorumlar 0 hisse senetleri 5K Views 0 önizleme
-
Point Of Care Diagnostics Market Growth Gains Pace as Rapid Testing ExpandsThe point of care diagnostics market is gaining momentum as healthcare providers increasingly seek faster, accessible, and efficient diagnostic solutions. According to Grand View Research, the market was valued at USD 21.7 billion in 2025 and is projected to grow from USD 22.6 billion in 2026 to USD 29.9 billion by 2033, registering a CAGR of 4.1% from 2026 to 2033. The ability of point of care...0 Yorumlar 0 hisse senetleri 544 Views 0 önizleme
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek